Colgate-Palmolive Company
COLGATE PALMOLIVE CO (Form: 4, Received: 11/08/2017 18:07:12)
FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

SADOVE STEPHEN I
2. Issuer Name and Ticker or Trading Symbol

COLGATE PALMOLIVE CO [ CL ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O COLGATE-PALMOLIVE COMPANY, 300 PARK AVENUE
3. Date of Earliest Transaction (MM/DD/YYYY)

11/6/2017
(Street)

NEW YORK, NY 10022
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   11/6/2017     M (1)    8000.0000   A $30.5500   36268.0000   D    
Common Stock   11/6/2017     M (1)    7000.0000   A $49.5000   43268.0000   D    
Common Stock   11/6/2017     M (1)    5780.0000   A $60.4500   49048.0000   D    
Common Stock   11/6/2017     S (2)    20780.0000   D $70.5190   (3) 28268.0000   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   $30.5500   11/6/2017     M   (1)       8000.0000      (4) 2/17/2019   Common Stock   8000.0000   $0.0000   0.0000   D    
Stock Option (Right to Buy)   $60.4500   11/6/2017     M   (1)       5780.0000      (5) 5/13/2019   Common Stock   5780.0000   $0.0000   0.0000   D    
Stock Option (Right to Buy)   $49.5000   11/6/2017     M   (1)       7000.0000      (6) 5/14/2018   Common Stock   7000.0000   $0.0000   0.0000   D    

Explanation of Responses:
(1)  Exercise of stock options awarded under the issuer's Non-Employee Director Stock Option Plan.
(2)  Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's Non-Employee Director Stock Option Plan.
(3)  Weighted average price, as these shares were sold in multiple transactions at prices ranging from $70.500 to $70.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(4)  Option became exercisable in one-third increments beginning on the first anniversary of the February 17, 2009 grant date.
(5)  Option became exercisable in one-third increments beginning on the first anniversary of the May 13, 2013 grant date.
(6)  Option became exercisable in one-third increments beginning on the first anniversary of the May 14, 2012 grant date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
SADOVE STEPHEN I
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
NEW YORK, NY 10022
X



Signatures
/s/ Kristine Hutchinson, Attorney-in-Fact 11/8/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.